Yunnan Longhai Natural Plant Pharmaceutical

Yunnan Longhai Natural Plant Pharmaceutical is a specialized pharmaceutical company based in Kunming, China, focusing on the development and production of natural plant-based medicines. The company is a leader in the utilization of Erigeron breviscapus, a traditional Chinese medicinal herb known as Dengzhanhua, to create treatments for cardiovascular and cerebrovascular diseases. Its core product line includes Dengzhan Xinyitong in various forms such as injections and capsules, which are widely used in the clinical treatment of stroke and paralysis. Yunnan Longhai operates a comprehensive business model that spans from the standardized cultivation of medicinal plants to high-tech extraction and large-scale GMP manufacturing. The firm is recognized as a key high-tech enterprise in Yunnan Province, leveraging the region's unique biodiversity to advance botanical drug research. Their products are primarily distributed within the Chinese domestic market, serving a critical role in traditional and integrative medicine practices.